Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study

出版年份 2017 全文链接

标题

作者

关键词

出版物

Volume 389, Issue 10069, Pages 612-620

出版商

Elsevier BV

发表日期

2017-01-07

DOI

10.1016/s0140-6736(16)31403-9

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started